Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP4 | Q8TDU9 | 5/20 | 0.60 |
| ▸ | RXFP3 | Q9NSD7 | 5/20 | 0.60 |
| ▸ | GLP1R | P43220 | 2/20 | 0.57 |
| ▸ | GCGR | P47871 | 2/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.56 |
| ▸ | F11 | P03951 | 1/20 | 0.56 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.56 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.56 |
| ▸ | MC4R | P32245 | 2/20 | 0.56 |
| ▸ | MC1R | Q01726 | 2/20 | 0.56 |
| ▸ | F12 | P00748 | 4/20 | 0.56 |
| ▸ | NECTIN4 | Q96NY8 | 2/20 | 0.55 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.55 |
| ▸ | KCNMB4 | Q86W47 | 1/20 | 0.55 |
| ▸ | MC3R | P41968 | 1/20 | 0.55 |
| ▸ | NPR1 | P16066 | 1/20 | 0.54 |
| ▸ | NPR3 | P17342 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28586826 | 0.98 | RXFP4 (0.61) | RXFP4RXFP3GLP1RGCGRRXFP1 | |
| SCHEMBL29438822 | 0.78 | KCNMA1 (0.66) | RXFP4RXFP3RXFP1F11MC4R | |
| SCHEMBL18375845 | 0.77 | EPHA2 (0.58) | F12 | |
| SCHEMBL18375815 | 0.77 | EPHA2 (0.58) | F12 | |
| SCHEMBL29467923 | 0.76 | MC4R (0.64) | RXFP1F11KCNA3KCNA1MC4R | |
| SCHEMBL29462295 | 0.76 | MC4R (0.70) | RXFP1F11MC4RMC1RF12 | |
| SCHEMBL29412264 | 0.76 | KCNA3 (0.57) | RXFP4RXFP3F11KCNA3KCNA1 | |
| SCHEMBL29353028 | 0.74 | F12 (0.57) | RXFP1F11MC4RMC1RF12 | |
| Acetic Acid SCHEMBL29363649 | 0.73 | NPR1 (0.87) | RXFP1F11KCNA3KCNA1MC4R | |
| SCHEMBL30883974 | 0.73 | KLK5 (0.55) | RXFP4RXFP3GLP1RGCGRF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260020591-A1 | FLAVOR BLENDS COMPRISING BRAZZEIN | PERFECT DAY INC (US) | 2026-01-22 | — | — | US | claimed |
| EP-4557971-A1 | FLAVOR BLENDS COMPRISING BRAZZEIN | Perfect Day, Inc. (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119999770-A | Liquid milk and preparation method and application thereof | 内蒙古蒙牛乳业（集团）股份有限公司 | 2025-05-16 | — | — | CN | claimed |
| EP-4523699-A1 | ANTI-INFLAMMATORY DERMATOLOGICAL COMPOSITION COMPRISING GLYCEROPHOSPHOINOSITOL, A LACTOFERRIN HYDROLYSATE AND A CANNABINOID, IN PARTICULAR FOR TREATING SEBORRHEIC DERMATITIS | FB Dermo srl (IT) | 2025-03-19 | — | — | EP | claimed |
| US-12208125-B2 | Stable dry powders and emulsions containing probiotics | VIRUN, INC. (US) | 2025-01-28 | — | — | US | claimed |
| CN-118878701-A | Bovine lactoferrin antibacterial peptide modified body and expression and application thereof in pichia pastoris | 江南大学 | 2024-11-01 | — | — | CN | claimed |
| US-12036267-B2 | Lactoferricin and lactoferrampin for treating infections | BICT S.R.L. (IT) | 2024-07-16 | — | — | US | claimed |
| US-11951116-B2 | Vaginal composition and use thereof | SINGAPORE ZE&ZINTERNATIONAL PTE. LTD (SG) | 2024-04-09 | — | — | US | claimed |
| WO-2024049307-A1 | MICROBIAL STRAINS, SUBSTRATES, AND SYSTEMS FOR PROTEIN EXPRESSION | DAISY LAB LIMITED (NZ) | 2024-03-07 | — | — | WO | claimed |
| CN-115850448-B | Lactoferrin polypeptide fragment, preparation method thereof, prepared antibody and application | 北京博奥森生物技术有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20230067261-A1 | METHODS FOR TREATING INFLAMMATORY CONDITIONS OF THE LUNGS | DEFENSIN THERAPEUTICS APS (DK) | 2023-03-02 | — | — | US | claimed |
| US-20230047790-A1 | STABLE DRY POWDERS AND EMULSIONS CONTAINING PROBIOTICS | VIRUN, INC. | 2023-02-16 | — | — | US | claimed |
| CN-115581219-A | Feeding management method for improving health of newborn calves | 河北省农林科学院粮油作物研究所 | 2023-01-10 | — | — | CN | claimed |
| CN-113354726-B | Lactoferrin active peptide and application thereof | 南方科技大学 | 2022-12-27 | — | — | CN | claimed |
| US-11491194-B2 | Stable dry powders and emulsions containing probiotics | VIRUN, INC. (US) | 2022-11-08 | — | — | US | claimed |
| US-20220273733-A1 | NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS | EVOLVE BIOSYSTEMS INC (US) | 2022-09-01 | — | — | US | claimed |
| US-11413328-B2 | Methods for treating inflammatory conditions of the lungs | NOVOZYMES A/S (DK) | 2022-08-16 | — | — | US | claimed |
| EP-4003300-A1 | NUTRITIVE COMPOSITIONS WITH BIOACTIVE PROTEINS | Evolve Biosystems Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114129553-A | anti-HPV bioprotein gel containing garlic extract | 安徽德莱康生物医疗科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| WO-2022029577-A1 | COMPOSITION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | BICT S.R.L. (IT) | 2022-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260020591-A1 | FLAVOR BLENDS COMPRISING BRAZZEIN | TAS2R14, TAS2R60, GPR119 | RXFP4 76/4885RXFP3 149/4885GLP1R 17/4885 |
| US-11491194-B2 | Stable dry powders and emulsions containing probiotics | FABP2, FABP6, MUC1 | RXFP4 3365/4885RXFP3 3550/4885GLP1R 3660/4885 |
| US-12208125-B2 | Stable dry powders and emulsions containing probiotics | FABP2, FABP6, MUC1 | RXFP4 3365/4885RXFP3 3550/4885GLP1R 3660/4885 |
| US-20230047790-A1 | STABLE DRY POWDERS AND EMULSIONS CONTAINING PROBIOTICS | FABP2, FABP6, MUC1 | RXFP4 3365/4885RXFP3 3550/4885GLP1R 3660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.